JP2004516236A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004516236A5 JP2004516236A5 JP2001583806A JP2001583806A JP2004516236A5 JP 2004516236 A5 JP2004516236 A5 JP 2004516236A5 JP 2001583806 A JP2001583806 A JP 2001583806A JP 2001583806 A JP2001583806 A JP 2001583806A JP 2004516236 A5 JP2004516236 A5 JP 2004516236A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antibody
- composition according
- factor
- antibody fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57143400A | 2000-05-15 | 2000-05-15 | |
| PCT/US2000/027438 WO2001087339A1 (en) | 2000-05-15 | 2000-10-05 | Antithrombotic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004516236A JP2004516236A (ja) | 2004-06-03 |
| JP2004516236A5 true JP2004516236A5 (enExample) | 2007-11-22 |
Family
ID=24283688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001583806A Pending JP2004516236A (ja) | 2000-05-15 | 2000-10-05 | 抗血栓剤 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20050037006A1 (enExample) |
| EP (2) | EP1825864A3 (enExample) |
| JP (1) | JP2004516236A (enExample) |
| KR (2) | KR20070116192A (enExample) |
| CN (2) | CN101134107A (enExample) |
| AT (1) | ATE345816T1 (enExample) |
| AU (2) | AU7858400A (enExample) |
| BR (1) | BR0015872A (enExample) |
| CA (1) | CA2411369A1 (enExample) |
| CZ (1) | CZ20023778A3 (enExample) |
| DE (1) | DE60032029T2 (enExample) |
| ES (1) | ES2277597T3 (enExample) |
| HU (1) | HU225874B1 (enExample) |
| IL (1) | IL152831A0 (enExample) |
| MX (1) | MXPA02011385A (enExample) |
| NO (1) | NO20025463L (enExample) |
| NZ (1) | NZ522632A (enExample) |
| PL (1) | PL360060A1 (enExample) |
| WO (1) | WO2001087339A1 (enExample) |
| ZA (1) | ZA200209265B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8980952B2 (en) | 2002-03-20 | 2015-03-17 | University Of Maryland, Baltimore | Methods for treating brain swelling with a compound that blocks a non-selective cation channel |
| PT2438913T (pt) | 2002-03-20 | 2020-05-27 | Us Veterans Affairs | Canal de catiões não seletivos em células neurais e compostos que bloqueiam o canal para utilização no tratamento de edema cerebral |
| US7872048B2 (en) | 2004-09-18 | 2011-01-18 | University Of Maryland, Baltimore | Methods for treating spinal cord injury with a compound that inhibits a NCCa-ATP channel |
| EP2359832A3 (en) | 2004-09-18 | 2011-11-23 | University of Maryland, Baltimore | Therapeutic agents targeting the NCCA-ATP channel and methods of use thereof |
| EP3103451A1 (en) | 2007-01-12 | 2016-12-14 | University of Maryland, Baltimore | Targetting ncca-atp channel for organ protection following ischemic episode |
| CA2974689C (en) | 2007-06-22 | 2020-02-25 | The United States Of America As Represented By The Department Of Veters Affairs | Inhibitors of ncca-atp channels for therapy |
| DK2202245T3 (en) | 2007-09-26 | 2016-11-21 | Chugai Pharmaceutical Co Ltd | A method of modifying an antibody isoelectric point VIA amino acid substitution in CDR |
| AU2008326348B2 (en) * | 2007-11-21 | 2014-01-30 | Oregon Health & Science University | Anti-factor XI monoclonal antibodies and methods of use thereof |
| US9518128B2 (en) | 2011-12-14 | 2016-12-13 | Janssen Pharmaceuticals, Inc. | Thrombin-binding antibody molecules |
| GB201121513D0 (en) * | 2011-12-14 | 2012-01-25 | Cambridge Entpr Ltd | Thrombin-binding antibody molecules and uses thereof |
| US20200231701A1 (en) * | 2016-12-23 | 2020-07-23 | Novartis Ag | Methods of treatment with anti-factor xi/xia antibodies |
| WO2018199214A1 (ja) | 2017-04-27 | 2018-11-01 | 中外製薬株式会社 | 薬物動態が改善された血液凝固第ｉｘ因子 |
| US20240018503A1 (en) * | 2017-04-27 | 2024-01-18 | Chugai Seiyaku Kabushiki Kaisha | Coagulation factor ix with improved pharmacokinetics |
| CN115448985A (zh) * | 2021-06-08 | 2022-12-09 | 上海循曜生物科技有限公司 | 新型抗栓抗体 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2049655C (en) * | 1990-09-17 | 1996-11-12 | Akio Odawara | Pharmaceutical composition for inhibiting platelet aggregation |
| MA24512A1 (fr) * | 1996-01-17 | 1998-12-31 | Univ Vermont And State Agrienl | Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose |
| WO2000007626A1 (en) * | 1998-08-07 | 2000-02-17 | Smithkline Beecham Corporation | Use of anti-coagulation factor antibodies as long-lasting protective agents |
| AU766551C (en) * | 1998-08-28 | 2005-02-17 | Genentech Inc. | Human anti-factor IX/IXa antibodies |
-
2000
- 2000-10-05 CA CA002411369A patent/CA2411369A1/en not_active Abandoned
- 2000-10-05 HU HU0301804A patent/HU225874B1/hu not_active IP Right Cessation
- 2000-10-05 EP EP06124420A patent/EP1825864A3/en active Pending
- 2000-10-05 EP EP00968710A patent/EP1282444B1/en not_active Expired - Lifetime
- 2000-10-05 CN CNA200710141110XA patent/CN101134107A/zh active Pending
- 2000-10-05 MX MXPA02011385A patent/MXPA02011385A/es active IP Right Grant
- 2000-10-05 KR KR1020077027348A patent/KR20070116192A/ko not_active Ceased
- 2000-10-05 JP JP2001583806A patent/JP2004516236A/ja active Pending
- 2000-10-05 KR KR1020027015403A patent/KR20030034071A/ko not_active Ceased
- 2000-10-05 DE DE60032029T patent/DE60032029T2/de not_active Expired - Fee Related
- 2000-10-05 NZ NZ522632A patent/NZ522632A/en unknown
- 2000-10-05 AU AU7858400A patent/AU7858400A/xx active Pending
- 2000-10-05 AT AT00968710T patent/ATE345816T1/de not_active IP Right Cessation
- 2000-10-05 CN CNB008197237A patent/CN100339132C/zh not_active Expired - Fee Related
- 2000-10-05 AU AU2000278584A patent/AU2000278584B2/en not_active Ceased
- 2000-10-05 WO PCT/US2000/027438 patent/WO2001087339A1/en not_active Ceased
- 2000-10-05 ES ES00968710T patent/ES2277597T3/es not_active Expired - Lifetime
- 2000-10-05 BR BR0015872-0A patent/BR0015872A/pt not_active IP Right Cessation
- 2000-10-05 PL PL36006000A patent/PL360060A1/xx unknown
- 2000-10-05 CZ CZ20023778A patent/CZ20023778A3/cs unknown
- 2000-10-05 IL IL15283100A patent/IL152831A0/xx unknown
-
2002
- 2002-11-14 ZA ZA200209265A patent/ZA200209265B/xx unknown
- 2002-11-14 NO NO20025463A patent/NO20025463L/no not_active Application Discontinuation
-
2003
- 2003-08-11 US US10/638,777 patent/US20050037006A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004516236A5 (enExample) | ||
| LU92255I2 (fr) | Ocriplasmine et ses dérivés pharmaceutiquement acceptables (JETREA) | |
| Lijnen et al. | Fibrinolytic agents: mechanisms of activity and pharmacology | |
| IL215891A (en) | Hepatitis C Serine Protease Inhibitors, Pharmaceutical Compounds Containing Them, and Their Use in Preparing Drugs to Treat Hepatitis C Infections | |
| MY129356A (en) | Electrospun pharmaceutical compositions | |
| MXPA04005755A (es) | Combinacion de inhibidores de proteasa dependientes del citocromo p450. | |
| WO2001068645A3 (en) | N-cyanomethylcarboxamides and their use as protease inhibitors | |
| EP1825864A3 (en) | Antithrombotic agents | |
| WO2003008637A3 (en) | Use of genotyping in the individualization of therapy | |
| DK1227797T3 (da) | Farmaceutiske faststofdispersionsformuleringer | |
| WO2002022107A3 (en) | Pharmaceutical composition having modified carrier | |
| SE0000303D0 (sv) | Novel compounds | |
| WO2003053999A3 (de) | Selektive arylguanidinpeptide als urokinaseinhibitoren | |
| WO2002057246A3 (en) | Inhibitors of cruzipain and other cysteine proteases | |
| CA2007075A1 (en) | New thrombolytic compositions | |
| BRPI0317780B8 (pt) | uso de supositório de estreptoquinase com ação trombolítica | |
| Thomson | New thrombolytic drugs | |
| MY120631A (en) | Novel pharmaceutical combination having analgesic activity | |
| JP2001521898A5 (ja) | 心筋虚血およびアンギナの処置用医薬の製造のためのキナプリルの使用 | |
| TR200100414A2 (tr) | Parasetamol yeni enjekte edilebilir çözeltileri ve aktif farmasötik maddeler ile kombinasyon halindeki enjekte edilebilir çözeltileri |